semaglutide bone density loss A study presented at the #AAOS2026 Annual Meeting revealed GLP-1 receptor agonist use was associated with a 29% higher risk of osteoporosis after five years. As these medications become more widely used Recent Updates on Diabetes and

L-Carnitine Converts fat into energy for better performance and endurance

But a recent phase 3 clinical trial has shown that a new type of oral weight-loss pill may have overcome these issues proving to be more effective than the current oral semaglutide products on the market

Look Beyond the Number on the Scale Progress with GLP-1 treatment is not always reflected immediately through body weight alone

What microdosing GLP-1s means, and why it could be the next big thing in personalized medicine

One of the most powerful internal allies for your skin is a naturally occurring antioxidant called glutathione

Nick Down over 35lbs